SCHEMBL25910705

SCHEMBL25910705

CC(=O)Nc1nccc(Oc2ccc3nc(-c4cnc(NC(C)C)n(C)c4=O)ccc3c2)n1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 5/20 0.47
▸ PDGFRA P16234 4/20 0.47
▸ PDGFRB P09619 3/20 0.47
▸ LCK P06239 1/20 0.47
▸ KIT P10721 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ PTK6 Q13882 1/20 0.47
▸ BRAF P15056 2/20 0.36
▸ SCN9A Q15858 8/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ SYK P43405 1/20 0.34
▸ SCN7A Q01118 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SCN10A Q9Y5Y9 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ MCHR1 Q99705 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25910706 0.93 CSF1R (0.46) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25909917 0.87 PDGFRB (0.52) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910925 0.87 CSF1R (0.47) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910037 0.87 CSF1R (0.50) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25911894 0.86 CSF1R (0.51) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25914975 0.85 CSF1R (0.47) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25913096 0.85 CSF1R (0.49) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25909920 0.85 CSF1R (0.45) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25909900 0.84 CSF1R (0.54) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910028 0.83 CSF1R (0.53) CSF1RPDGFRAPDGFRBLCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback